Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

CNBC’s Annika Kim Constantino and Albert Bourla, Pfizer CEO, join ‘The Exchange’ to discuss Pfizer’s Q3 earnings, patent expirations, and more.